AstraZeneca · 8 hours ago
AI Insights Innovator Intern (Graduate-Level)
AstraZeneca is a global biopharmaceutical company, and they are seeking a Graduate-Level AI Insights Innovator Intern. The role involves building an information repository, developing product concepts, creating prototypes, and summarizing projects for stakeholders.
BiopharmaBiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Build information repository: Collect and organize insight summaries, including full context of the projects from Breast MDx team members
Design: Develop and socialize product concept, collect user needs and requirements from a broader MDx team to inform prototype design
Build prototype data product
Test basic functionalities: develop simple test cases and work with selected stakeholders to verify accuracy and functionality
Summarize the project and present to the organization stakeholders
Qualification
Required
Master's students majoring Computer Science or a related field
Candidates must have an expected graduation date after August 2026
Data/AI Literacy: Understanding of how AI-powered search or chat tools work; understanding limitations, responsible use, and prompting; willingness to learn quickly
Rapid Prototyping: Demonstrated experience in assembling a working prototype, comfort using available platforms, templates, or low-code tools to demonstrate value
User-Centered Product Thinking: Demonstrated experience in translating needs into simple, useful concepts; prioritizing must-haves vs. nice-to-haves; documenting basic requirements and success criteria
US Work Authorization is required at time of application
Ability to report onsite to Gaithersburg, MD site 3 days per week
Preferred
Project Management & Ownership: Planning a 12 week roadmap, managing tasks and milestones, and keeping stakeholders updated; delivering on time with a concise demo and documentation
Enthusiasm for collaboration, cross-functional projects, public speaking, and presentation design
Company
AstraZeneca
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.
Funding
Current Stage
Public CompanyTotal Funding
$5.26B2024-07-30Post Ipo Debt· $1.51B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B
Leadership Team
Recent News
2026-01-14
Company data provided by crunchbase